CONMED Corporation Announces Second Quarter 2008 Financial Results
[2008-7-28]
Tag : Gynecology Equipment
CONMED Corporation ( Nasdaq: CNMD ) today announced that it had better than expected second quarter2008 sales growth of 13.9% over the second quarter of 2007. Thesesales drove a 34% expansion of earnings per share when compared toGAAP EPS in the second quarter 2007 and 23% when compared tonon-GAAP adjusted EPS. As discussed below under "Use of Non-GAAPFinancial Measures," the Company presents various non-GAAPfinancial measures in this release. Investors should considernon-GAAP measures in addition to, and not a substitute for, orsuperior to, financial performance measures prepared in accordancewith GAAP. Please refer to the attached reconciliation between GAAPand non-GAAP financial measures.
"CONMED's focus on execution of our plan to expand ourprofitability at a rate faster than the top-line growth was thedriving force behind our successful second quarter. The salesgrowth this quarter was a result of stronger worldwide sales acrossour product portfolio with particular strength internationally.Given the strong financial performance for the first half of 2008and our confidence in the remainder of the year, we have increasedour guidance for the full year 2008," commented Mr. Joseph J.Corasanti, President and Chief Executive Officer.
Year-Over-Year Quarterly Highlights
-- GAAP EPS grew to $0.43
-- 34% increase vs. 2Q 2007 GAAP EPS of $0.32 -- 23% increase vs.2Q 2007 non-GAAP EPS of $0.35
-- Quarterly Sales Increase to $192.8 million - a new quarterlyrecord
CONMED Corporation ( Nasdaq: CNMD ) today announced that it had better than expected second quarter2008 sales growth of 13.9% over the second quarter of 2007. Thesesales drove a 34% expansion of earnings per share when compared toGAAP EPS in the second quarter 2007 and 23% when compared tonon-GAAP adjusted EPS. As discussed below under "Use of Non-GAAPFinancial Measures," the Company presents various non-GAAPfinancial measures in this release. Investors should considernon-GAAP measures in addition to, and not a substitute for, orsuperior to, financial performance measures prepared in accordancewith GAAP. Please refer to the attached reconciliation between GAAPand non-GAAP financial measures.
"CONMED's focus on execution of our plan to expand ourprofitability at a rate faster than the top-line growth was thedriving force behind our successful second quarter. The salesgrowth this quarter was a result of stronger worldwide sales acrossour product portfolio with particular strength internationally.Given the strong financial performance for the first half of 2008and our confidence in the remainder of the year, we have increasedour guidance for the full year 2008," commented Mr. Joseph J.Corasanti, President and Chief Executive Officer.
Year-Over-Year Quarterly Highlights
-- GAAP EPS grew to $0.43
-- 34% increase vs. 2Q 2007 GAAP EPS of $0.32 -- 23% increase vs.2Q 2007 non-GAAP EPS of $0.35
-- Quarterly Sales Increase to $192.8 million - a new quarterlyrecord
Related News »
In Focus »
Chemical Restricted
Engaging in concept of environmental protection for the Green Olympics, the chemical industry ..
- U.S. team to provide all Olympic ..
- Investors eye coal-to-oil conversion ..
- Chemical education in need of reform
B2B Keywords:
International market Chinese Importer Wholesale trade Wholesale products World trade Wholesale distributors International trade Foreign trade Wholesale distributor Importers Import export business Sell online Help u sell Global trade How to market a product Online supplier Wholesale product
International market Chinese Importer Wholesale trade Wholesale products World trade Wholesale distributors International trade Foreign trade Wholesale distributor Importers Import export business Sell online Help u sell Global trade How to market a product Online supplier Wholesale product




